![Pieter van der Meijden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pieter van der Meijden
Directeur/Membre du Conseil chez
ISA Pharmaceuticals BV
Profil
Pieter van der Meijden currently works at i-Optics BV, as Director and ISA Pharmaceuticals BV, as Member-Supervisory Board.
Mr. van der Meijden also formerly worked at NIBC Bank NV, as Deputy Director, Gimv Nederland BV, as Managing Director, and Berk Management BV, as Managing Partner in 2007.
Mr. van der Meijden received his graduate degree from Erasmus University Rotterdam.
Postes actifs de Pieter van der Meijden
| Sociétés | Poste | Début |
|---|---|---|
ISA Pharmaceuticals BV
 ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Develops novel therapeutic vaccines for cancer and infectious diseases | Directeur/Membre du Conseil | - |
i-Optics BV
 i-Optics BV Medical SpecialtiesHealth Technology Develops and produces eye diagnosis and therapeutic solutions | Directeur/Membre du Conseil | - |
Anciens postes connus de Pieter van der Meijden
| Sociétés | Poste | Fin |
|---|---|---|
Berk Management BV
 Berk Management BV Investment ManagersFinance BM's investment objective is to create value and growth. They invest in family-owned and established mid-sized firms in The Netherlands with a minimum turnover of EUR 10 million. They prefer management buyout situations, financing expansion and transactions involving succession issues within family-run firms. They do not invest in start-ups or in turnaround situations. They look for firms operating in a market niche with a leading position or potential for market leadership. BM seeks robust management teams managing with a proven business model. They look for stable, profitable cash flows. They invest across a range of sectors and have invested in safety products for bathrooms, linen rental, hospital-related communications, publishing, cleaning products, and consultancy products. BM takes both majority and minority stakes and generally acts as lead-investor. They invest between EUR 1.5 million and EUR 3 million per transaction. They are active and involved investment partners. They take Board positions and work closely with their portfolio firms' management team. BM typically foresees exits between four to six years. | Corporate Officer/Principal | 01/01/2007 |
Gimv Nederland BV
 Gimv Nederland BV Investment ManagersFinance Gimv-Nederland is a small- and medium-sized buyout specialist focused on Germany, the Netherlands and Belgium. They are an active, long-term manager which targets profitable medium-sized manufacturing, service and trading companies with good market positions. They focus on companies with positive earnings and sales of EUR 20-200 million, aiming to increase the investee company's value over the long-term. In addition to providing equity capital, the firm partners with investee management, providing advice and expertise as a majority or minority shareholder. They also provide growth capital in later rounds of financing until the portfolio company is self-financed or ready for an IPO. Gimv-Nederland's investments consist primarily of MBOs which involve expansion financing, ownership succession, business division spin-offs or other changes in shareholder structure. Gimv-NI's investment managers commit some of their personal capital to every investment. | Corporate Officer/Principal | - |
NIBC Bank NV
 NIBC Bank NV Regional BanksFinance Provides banking services | Corporate Officer/Principal | - |
Formation de Pieter van der Meijden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
NIBC Bank NV
NIBC Bank NV Regional BanksFinance Provides banking services | Finance |
Gimv Nederland BV
Gimv Nederland BV Investment ManagersFinance Gimv-Nederland is a small- and medium-sized buyout specialist focused on Germany, the Netherlands and Belgium. They are an active, long-term manager which targets profitable medium-sized manufacturing, service and trading companies with good market positions. They focus on companies with positive earnings and sales of EUR 20-200 million, aiming to increase the investee company's value over the long-term. In addition to providing equity capital, the firm partners with investee management, providing advice and expertise as a majority or minority shareholder. They also provide growth capital in later rounds of financing until the portfolio company is self-financed or ready for an IPO. Gimv-Nederland's investments consist primarily of MBOs which involve expansion financing, ownership succession, business division spin-offs or other changes in shareholder structure. Gimv-NI's investment managers commit some of their personal capital to every investment. | Finance |
Berk Management BV
Berk Management BV Investment ManagersFinance BM's investment objective is to create value and growth. They invest in family-owned and established mid-sized firms in The Netherlands with a minimum turnover of EUR 10 million. They prefer management buyout situations, financing expansion and transactions involving succession issues within family-run firms. They do not invest in start-ups or in turnaround situations. They look for firms operating in a market niche with a leading position or potential for market leadership. BM seeks robust management teams managing with a proven business model. They look for stable, profitable cash flows. They invest across a range of sectors and have invested in safety products for bathrooms, linen rental, hospital-related communications, publishing, cleaning products, and consultancy products. BM takes both majority and minority stakes and generally acts as lead-investor. They invest between EUR 1.5 million and EUR 3 million per transaction. They are active and involved investment partners. They take Board positions and work closely with their portfolio firms' management team. BM typically foresees exits between four to six years. | Finance |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
i-Optics BV
i-Optics BV Medical SpecialtiesHealth Technology Develops and produces eye diagnosis and therapeutic solutions | Health Technology |
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Develops novel therapeutic vaccines for cancer and infectious diseases | Health Technology |
